Minghui Pharmaceutical Overview
- Year Founded
-
2018
- Status
-
IPO Registration
- Employees
-
127
- Latest Deal Type
-
IPO
- (Postponed)
- Financing Rounds
-
6
Minghui Pharmaceutical General Information
Description
Developer of clinical-stage oncology and autoimmune therapeutics designed for solid tumors and immune-mediated diseases. The company provides proprietary antibody-drug conjugates (ADCs), bispecific antibodies, and targeted inhibitors, enabling patients with advanced cancers and autoimmune conditions with innovative and potentially safer treatment options.
Contact Information
Website
www.minghuipharma.comCorporate Office
- Room 1002, 10/F, Building 1
- No. 333 Shengrong Road, China (Shanghai) Pilot Free Trade Zone, PRC
- Shanghai, 201203
- China
Corporate Office
- Room 1002, 10/F, Building 1
- No. 333 Shengrong Road, China (Shanghai) Pilot Free Trade Zone, PRC
- Shanghai, 201203
- China
Minghui Pharmaceutical Timeline
Minghui Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Minghui Pharmaceutical Patents
Minghui Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026171078-A1 | Anti-c-met antibody-drug conjugate and use thereof | Pending | 12-Feb-2025 | ||
| WO-2026171088-A1 | Anti-cdcp1 antibody-drug conjugate and use thereof | Pending | 12-Feb-2025 | ||
| WO-2026153364-A1 | Preparation method for jak inhibitor compound, and crystal form and intermediate of jak inhibitor compound | Pending | 14-Jan-2025 | ||
| WO-2025241867-A1 | Anti-b7-h4 antibody-drug conjugate and application thereof | Pending | 24-May-2024 | ||
| WO-2025241869-A1 | Anti-psma antibody-drug conjugate and use thereof | Pending | 24-May-2024 |
Minghui Pharmaceutical Signals
Minghui Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Minghui Pharmaceutical FAQs
-
When was Minghui Pharmaceutical founded?
Minghui Pharmaceutical was founded in 2018.
-
Where is Minghui Pharmaceutical headquartered?
Minghui Pharmaceutical is headquartered in Shanghai, China.
-
What is the size of Minghui Pharmaceutical?
Minghui Pharmaceutical has 127 total employees.
-
What industry is Minghui Pharmaceutical in?
Minghui Pharmaceutical’s primary industry is Drug Discovery.
-
Is Minghui Pharmaceutical a private or public company?
Minghui Pharmaceutical is a Private company.
-
What is Minghui Pharmaceutical’s current revenue?
The current revenue for Minghui Pharmaceutical is .
-
How much funding has Minghui Pharmaceutical raised over time?
Minghui Pharmaceutical has raised $289M.
-
Who are Minghui Pharmaceutical’s investors?
5Y Capital, BioTrack Capital, Boyuan Capital, OrbiMed, and Qiming Venture Partners are 5 of 12 investors who have invested in Minghui Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process